News about Johnson & Johnson
Lower prices could be on the horizon.
Including Disney's Bob Iger and GM's Mary Barra
But Dupixent's high cost could be a problem.
The industry is wary of the coming FDA streamlining.
Videos about Johnson & Johnson
Group Worldwide Chairman Sandi Peterson explains
Group worldwide chairman Sandi Peterson explains
According to this Johnson & Johnson exec